BRODNEY, MICHAEL AARON,DAVOREN, JENNIFER ELIZABETH,DOUNAY, AMY BETH,EFREMOV, IVAN VIKTOROVICH,GRAY, DAVID LAWRENCE FIRMAN,GREEN, MICHAEL ERIC,HENDERSON, JACLYN LOUISE,LEE, CHEWAH,MENTE, SCOT RICHARD,O
申请号：
CA2916653
公开号：
CA2916653C
申请日:
2014.06.13
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention provides, in part, compounds of Formula (I) andpharmaceutically acceptable salts thereof；processes for the preparation of； intermediates used in the preparation of；and compositions containing such compounds or salts, andtheir uses for treating D1 -mediated (or D1-associated) disorders including,e.g., schizophrenia (e.g., its cognitive and negativesymptoms), cognitive impairment (e.g., cognitive impairment associated withschizophrenia, AD, PD, or pharmacotherapy therapy),age-related cognitive decline, dementia, and Parkinson's disease.
